- Home
- GCBC vs DCTH Comparison
GCBC vs DCTH Comparison
Compare GCBC & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GCBC | DCTH |
|---|---|---|
| Founded | 1889 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 374.8M | 350.7M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | GCBC | DCTH |
|---|---|---|
| Price | $24.30 | $9.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | 12.0K | ★ 481.6K |
| Earning Date | 01-21-2026 | 03-05-2026 |
| Dividend Yield | ★ 1.66% | N/A |
| EPS Growth | ★ 39.39 | N/A |
| EPS | ★ 2.15 | 0.03 |
| Revenue | ★ $81,989,000.00 | $79,603,000.00 |
| Revenue This Year | N/A | $132.21 |
| Revenue Next Year | N/A | $33.88 |
| P/E Ratio | ★ $11.20 | $288.94 |
| Revenue Growth | 24.51 | ★ 251.54 |
| 52 Week Low | $20.00 | $8.12 |
| 52 Week High | $27.62 | $18.23 |
Technical Indicators
Market Signals| Indicator | GCBC | DCTH |
|---|---|---|
| Relative Strength Index (RSI) | 63.26 | 38.90 |
| Support Level | $23.55 | $9.74 |
| Resistance Level | $23.34 | $11.15 |
| Average True Range (ATR) | 0.61 | 0.43 |
| MACD | 0.25 | -0.10 |
| Stochastic Oscillator | 92.31 | 11.28 |
Price Performance
Historical ComparisonAbout GCBC Greene County Bancorp Inc.
Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.